1-10 of 1988 results

Proposed Design and Place SEPP – creating further complexity in our planning system?
Insight 06 Apr 2021

The Explanation of Intended Effect for the proposed Design and Place SEPP, presently on public exhibition, signals major change to the assessment requirements for all development in NSW. Improving design outcomes in the built environment is important, but will the proposed SEPP be the right vehicle to achieve this objective, or will it add another layer to an already complex planning system? ...

Vietnam merger control guide
Insight 01 Apr 2021

Vietnam's new merger control regime took effect from 15 May 202. The new regime substantially expands the scope of transactions subject to the merger filing requirement and thereby captures more M&A transactions in Vietnam offshore.  ...

Class action risk in 2021
Insight 30 Mar 2021

Australia’s class action landscape remains dynamic and complex. 2020 was characterised by an increase in filings, continuing uncertainty around the impact of COVID-19, and a consistently high level of consumer claims. ...

ACCC's 2021 product safety priorities
Insight 30 Mar 2021

The ACCC announced its Product Safety Priorities for 2021, including: Button batteries, Quad bikes, Toppling furniture and infant sleeping products, and E-commerce and the Australian Product Safety Pledge. ...

Will negative price risk increase following changes to dispatch obligations under the National Electricity Rules?
Insight 25 Mar 2021

Semi-scheduled generators, such as wind and solar farms, will face increased exposure to negative price risk following a new rule made by the Australian Energy Market Commission (AEMC). ...

Repurposing existing medicines – industry to have its say in reshaping Australia's regulatory future
Insight 25 Mar 2021

The Therapeutics Goods Administration (the TGA) is consulting with the public and industry to potentially reform regulatory and reimbursement frameworks, to incentivise the repurposing of existing medicines. Off-label use (where a medicine is used for a disease or medical condition for which it does ...

Proposed new responsible lending laws pass the House of Representatives
Insight 24 Mar 2021

On Monday 15 March 2021, the National Consumer Credit Protection Amendment (Supporting Economic Recovery) Bill 2020 passed the House of Representatives, and was introduced in the Senate the following day. This followed the release of the Senate Economics Legislation Committee Report on the Bill. ...

'Remediation' as a legal term
Insight 24 Mar 2021

ASIC's recent consultation paper (CP335) on proposed changes to its remediation guidance (RG256) may have created further space between what is legally required of remediations and what ASIC may expect of them. ...

Nucleus – corporate law developments: ASIC restricts effectiveness of certain director resignations; new ASIC whistleblower immunity policy; and other updates
Insight 22 Mar 2021

ASIC restricts effectiveness of director resignations and introduces new whistleblower immunity policy; FIRB commences evaluation of changes to foreign investment laws; ACCC flags further reform of merger review process in 2021; lapsing of electronic signing and virtual meeting protocols ...

Signing documents in a pandemic
Insight 19 Mar 2021

The pandemic has focused minds on the need for law reform, to clarify that documents can be signed electronically, so that they are fully accepted in the market, and also to allow signatures to be witnessed remotely over audiovisual links. This timeline outlines the changes to legislation changes. ...

Refine

From
To